SPOSITO, MARCO
 Distribuzione geografica
Continente #
EU - Europa 1.779
NA - Nord America 1.687
AS - Asia 1.355
SA - Sud America 170
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 60
OC - Oceania 7
Totale 5.126
Nazione #
US - Stati Uniti d'America 1.617
RU - Federazione Russa 865
SG - Singapore 642
IT - Italia 309
CN - Cina 224
DE - Germania 179
HK - Hong Kong 143
VN - Vietnam 137
BR - Brasile 130
FI - Finlandia 111
GB - Regno Unito 77
FR - Francia 46
CA - Canada 43
BD - Bangladesh 37
IN - India 37
NL - Olanda 33
KR - Corea 31
PL - Polonia 31
IE - Irlanda 26
SE - Svezia 26
ID - Indonesia 25
JP - Giappone 21
ES - Italia 15
TR - Turchia 15
AR - Argentina 14
BJ - Benin 13
TG - Togo 13
AT - Austria 12
MX - Messico 12
UA - Ucraina 12
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
NG - Nigeria 9
VE - Venezuela 8
CO - Colombia 7
AU - Australia 6
EC - Ecuador 6
IQ - Iraq 6
MA - Marocco 6
UZ - Uzbekistan 6
CR - Costa Rica 5
LT - Lituania 5
EG - Egitto 4
KZ - Kazakistan 4
BE - Belgio 3
BO - Bolivia 3
KE - Kenya 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PK - Pakistan 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
RO - Romania 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
WS - Samoa 1
Totale 5.066
Città #
Singapore 356
Moscow 325
Ashburn 277
Dallas 274
San Jose 231
Hong Kong 142
Munich 128
Council Bluffs 109
Verona 91
Helsinki 66
New York 50
Beijing 45
Los Angeles 42
The Dalles 41
Ho Chi Minh City 37
Milan 36
Chandler 35
Hanoi 35
Dublin 25
London 24
Santa Clara 22
Chicago 19
Lappeenranta 19
São Paulo 19
Tokyo 19
Warsaw 19
Meda 18
Buffalo 17
Turku 16
Montreal 15
Atlanta 14
Frankfurt am Main 14
Redondo Beach 14
Cotonou 13
Jakarta 13
Lomé 13
Brooklyn 11
Nuremberg 11
Orem 11
Da Nang 10
Denver 10
Abuja 9
Amsterdam 9
Barnet 9
Toronto 9
Columbus 8
Istanbul 8
Johannesburg 8
Mumbai 8
Stockholm 8
Trento 8
Belo Horizonte 7
Boardman 7
Jacksonville 7
Manchester 7
Naples 7
Phoenix 7
Turin 7
Vienna 7
Biên Hòa 6
Boston 6
Chennai 6
Jyväskylä 6
Kyiv 6
New Delhi 6
Rome 6
Washington 6
Charlotte 5
Guangzhou 5
Isola della Scala 5
Krakow 5
Ottawa 5
Poplar 5
San Francisco 5
San José 5
Seattle 5
Tashkent 5
Ann Arbor 4
Baghdad 4
Bologna 4
Bussolengo 4
Falkenstein 4
Haiphong 4
Houston 4
Louisville 4
Maceió 4
Madrid 4
Marseille 4
Mexico City 4
Paris 4
Philadelphia 4
Piscataway 4
Pittsburgh 4
Querétaro 4
Seoul 4
Shenyang 4
Thái Nguyên 4
Wilmington 4
Brno 3
Brussels 3
Totale 3.014
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 314
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 193
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 188
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 182
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 168
A cross-sectional study exploring the perception of exercise oncology in the Italian population 161
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 159
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 157
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 156
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 155
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 155
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study 145
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 137
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 134
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer 133
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 133
Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers 132
Exercise and bone health in cancer: enemy or ally? 129
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 128
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials 126
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 126
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study 125
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 123
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report 122
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 120
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 108
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 108
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 103
Overcome the Fear of Exercise in Patients With Bone Metastases: A Qualitative Study on Patients' Perception 102
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer 101
Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise 96
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review 94
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 93
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study 85
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 81
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates 77
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 76
Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report 49
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 40
Impact of Long-Term Structured Exercise on Body Composition in an NTRK Fusion-Positive NSCLC Patient Treated With Entrectinib 40
Microbiome and EGFR-mutant non-small cell lung cancer: a complex interplay 19
Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity 14
Real-world feasibility and effectiveness of a personalized exercise program during cancer treatment: results from the CHOiCE prospective study 12
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision 11
Impact of the Oncologist's Recommendation on Exercise Levels and Quality of Life in Patients With Lung Cancer: The ORE Randomized Controlled Trial 10
Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors 6
Totale 5.126
Categoria #
all - tutte 19.810
article - articoli 19.810
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 11 0 0 3 1 1 1 1 2 5 10
2022/2023127 3 11 8 15 6 31 0 15 15 8 8 7
2023/2024279 5 8 19 27 36 31 33 15 10 30 41 24
2024/20251.102 47 24 43 188 27 61 96 73 172 63 115 193
2025/20263.352 154 172 297 575 816 181 312 174 286 236 86 63
2026/2027188 57 131 0 0 0 0 0 0 0 0 0 0
Totale 5.126